ENHERTU® has demonstrated clinically meaningful progression-free survival and overall survival in topline results from the primary analysis of the ongoing DESTINY-PanTumor02 Phase II trial.
The.
As a continuation of the brand s First Strides initiative and in collaboration with Just Women s Sports and the Women s Sports Foundation, Johnnie Walker is working to create more visibility for.
BioNTech SE and the UK government have jointly agreed to provide up to 10,000 patients with personalised cancer immunotherapies by 2030.
Signing of this agreement builds on a memorandum of.